Yes what a great presentation as some of us have posted in the past, James again states:
6 trials, 4 of them funded outside of Kazia - pay for 2 get 6
they are trying to get in front of investors and it’s slowly happening but investor behaviour is slower than media - that’s slowly changing - we knew we are not on the radar yet
we are in the sweet spot as pi3k products take off and only GDC0084 crosses the blood brain barrier
the previous Genentech trial was on late stage patients and the new one isn’t it should perform extra well
our data in a week is going to be very exciting
the opportunity to fast track GDC084 cannot be over stated due to the short life expectancy of 9 months for kids with dipg
expecting signs from the study to be available in early 2019 in the new year - again reasons to be very excited - thank you st Jude’s
we are in his words ‘late in the game’ and have data coming through now after the recent years of setting it all up
we have our formal chemical name to take the drug through to registration Paxalisib this name will be used from 1st jan in comms on the program
2 presentations at SNO in a weeks time - ongoing ph2 clinical study on glioblastoma - really important efficacy data! - and also ph1 Advanced glioma as an oral presentation which is highly sort after not many get and this shows how interesting this all is
rich flow of new data from both programs in the new year and over the next 6 months
enough opex money to get over 3 to 4 key data readouts next year approx 9 months - I was bang on the nail there
5 good quality investor funds on register now
its not a given they will need to raise money there’s a very good chance they will partner with the coming readouts to provide funds
they have been very good at recruiting others to pay for trials with Paxalisib so far and they do hope to partner - just as per the plan! Thanks James
the recent raise was all about risk mitigation as we all new
so there you go all the important info in one video recently released - all you need do is just watch all of the above is mentioned here :
Enjoy!
KZA Price at posting:
41.0¢ Sentiment: Buy Disclosure: Held